Guidelines Oriented Approach to Lipid Lowering (GOAL) in Canada

NCT02537535 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2027

Last updated 2020-01-23

No results posted yet for this study

Summary

Cross-sectional observational study designed to identify and describe the care gap in guideline-oriented low density lipoprotein cholesterol (LDL-C) management in Canadian patients at high cardiovascular risk.

Conditions

Interventions

OTHER

survey

This is a cross-sectional study without specific intervention

Sponsors & Collaborators

  • Amgen

    collaborator INDUSTRY
  • Canadian Heart Research Centre

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2019-12-31
Completion
2019-12-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02537535 on ClinicalTrials.gov